DHA and X-Linked Retinitis Pigmentosa
NCT00100230
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
78
Enrollment
OTHER
Sponsor class
Conditions
Retinitis Pigmentosa
X-linked Genetic Diseases
Interventions
DRUG:
docosahexaenoic acid OR corn/soy oil placebo
Sponsor
Retina Foundation of the Southwest
Collaborators
[object Object]
[object Object]